Home » Current Affairs In-depths & Editorials » GS2 » Society & Social Justice » Social Justice » Social Sector » Health » Drugs/Pharmaceuticals » Thalidomide Tragedy

Thalidomide Tragedy

Santhosh Kumar 16/11/2023

Australia apologises for thalidomide tragedy mind map
Australia government formal apology
For thalidomide tragedy impact
Drug prescribed
In 1950s and 1960s
For morning sickness
Thalidomide
Sedative drug
Prescribed to pregnant women
To relieve pregnancy nausea
Effects
Malformation in unborn children
Limbs
Facial features
Internal organs
Lack of testing
Not tested on pregnant women
Led to global medical reforms
Statistics
Over 10,000 children affected
Approx 40% mortality within first year
Australian government's apology
Reflects values
Accountability
Empathy
Recognition of past failures
Demonstrates need for
Strictly enforced regulation
Drug testing
Marketing
Dispensing
Use

If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.

Related Posts

Carbon Offsetting

Carbon Offsetting

12/10/2021 / Australia, Global Warming & Climate Change, Policies/Plans/Guidelines/Frameworks

R21/Matrix-M vaccine

R21/Matrix-M vaccine

03/10/2023 / Diseases, Drugs/Pharmaceuticals

Bedaquiline upsc notes Source: The Wire Context A significant breakthrough An agreement reached between Nonprofit Global Drug Facility Johnson & Johnson Distribution of generic versions of bedaquiline In most low and middle-income countries About TB Caused by bacteria Primarily affects the lungs Can also impact other parts of the body Spreads through the air When an infected person coughs or sneezes A treatable but deadly infectious disease Causes 1.5 million deaths annually Treatment Bedaquiline has shown high success In treating drug-resistant TB Patent held by Johnson & Johnson Significance of the agreement Affordable access to the drug Enabled by the agreement Generic manufacturers in India expected to offer at an 80% lower price Goal To end TB Tender for bedaquiline to be launched soon Improved accessibility and affordability of the drug Brings hope for global efforts to eliminate TB by 2030 About Global Drug Facility (GDF) A non-profit organization Implements the UN-backed ‘The Stop TB Partnership’ To facilitate global access to quality-assured, affordable TB diagnostics and treatments About Stop TB Partnership Founded in 2001 A UN-hosted organization Brings together expertise From a broad spectrum of partners Country partners Regional partners Global partners Shared mission to end TB by 2030 Hosted and administered by United Nations Office for Project Services (UNOPS) In Geneva, Switzerland

16/07/2023 / Diseases, Drugs/Pharmaceuticals

MedTech Mitra mind map Recent News Launched Date 25 December 2023 Why Empower MedTech Innovators Advance Healthcare Solutions Reduce Import Dependence Current dependence up to 80% Enhance Medical Device Industry India's target for 2030 $50 billion industry Promote Indigenous Development Affordable and Quality MedTech devices Diagnostics What Online Portal Aims Assist MedTech Innovators Clinical Evaluation Regulatory Facilitation Uptake of New Products Features Support Research Regulatory Approval Collaboration Funding Handholding for Clinical Evaluations Regulatory Compliance Ease of Innovation Research and Development Rendering Service Government Initiatives Production-Linked Incentive Schemes Investments in Medical Drug Parks MedTech Research Policy MedTech Research Incentive Scheme National Medical Device Policy Scheme worth Rs 5,000 crore Promotion of Research Pharma and MedTech Sectors Where India Impact on Indian Healthcare Sector Who Collaboration Indian Council of Medical Research (ICMR) Central Drugs Standard Control Organisation (CDSCO) Under Guidance of NITI Aayog's Atal Innovation Mission How Virtual Launch Government Support Industry Collaboration Significance Empowers Start-ups Reduces Import Dependence Enhances MedTech Sector Rapid Growth Areas Robotics Artificial Intelligence (AI) Big Data Virtual Reality Nanotechnology Boosts Economy Target of $50 billion by 2030 Strengthens Universal Health Coverage Reach to Innermost Corners Contributes to Viksit Bharat Vision Holistic Approach to Health Vision for 2047 Challenges High Import Dependence Current State Up to 80% Import-Dependent Rapidly Changing Sector Need for Continuous Adaptation Way Forward Encourage Indigenous Innovations Increase Stakeholder Collaboration Strengthen Research and Development Expand MedTech Ecosystem

MedTech Mitra Initiative

28/12/2023 / Drugs/Pharmaceuticals, Healthcare

Categories: Australia, Drugs/Pharmaceuticals

Tags: 16.11.2023, Newsbits

Subscribe

0 Comments

Inline Feedbacks

View all comments

X